HUM vs MAZE · P/E 39, rev $117.76B vs $525.3M cap
Humana Inc (HUM) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the HUM and MAZE stock pages for the full models.
Not investment advice.